Transition probabilities of HER2-positive and HER2-negative breast cancer patients treated with Trastuzumab obtained from a clinical cancer registry dataset

Records of female breast cancer patients were selected from a clinical cancer registry and separated into three cohorts according to HER2-status (human epidermal growth factor receptor 2) and treatment with or without Trastuzumab (a humanized monoclonal antibody). Propensity score matching was used...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Data Brief
Autors principals: Pobiruchin, Monika, Bochum, Sylvia, Martens, Uwe M., Kieser, Meinhard, Schramm, Wendelin
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2016
Matèries:
Data Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4802671/
https://ncbi.nlm.nih.gov/pubmed/27054173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dib.2016.03.039
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars